These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 38953887)
21. Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma. Lu H; Ju DD; Yang GD; Zhu LY; Yang XM; Li J; Song WW; Wang JH; Zhang CC; Zhang ZG; Zhang R EBioMedicine; 2019 Feb; 40():276-289. PubMed ID: 30594556 [TBL] [Abstract][Full Text] [Related]
22. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation. Zhang Y; Wang S; Kang W; Liu C; Dong Y; Ren F; Wang Y; Zhang J; Wang G; To KF; Zhang X; Sung JJ; Chang Z; Yu J Oncogene; 2018 Jun; 37(26):3485-3500. PubMed ID: 29563608 [TBL] [Abstract][Full Text] [Related]
23. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling. Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118 [TBL] [Abstract][Full Text] [Related]
24. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling. Lin Y; Chen X; Lin L; Xu B; Zhu X; Lin X Cell Mol Biol Lett; 2024 May; 29(1):63. PubMed ID: 38698330 [TBL] [Abstract][Full Text] [Related]
25. DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression. Guturi KK; Sarkar M; Bhowmik A; Das N; Ghosh MK Breast Cancer Res; 2014 Dec; 16(6):496. PubMed ID: 25499975 [TBL] [Abstract][Full Text] [Related]
26. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling. Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067 [TBL] [Abstract][Full Text] [Related]
27. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway. Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116 [TBL] [Abstract][Full Text] [Related]
28. Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin. Liu C; Wang L; Jiang Q; Zhang J; Zhu L; Lin L; Jiang H; Lin D; Xiao Y; Fang W; Guo S Front Oncol; 2019; 9():211. PubMed ID: 31032220 [No Abstract] [Full Text] [Related]
29. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells. Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190 [TBL] [Abstract][Full Text] [Related]
30. DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway. Du C; Li DQ; Li N; Chen L; Li SS; Yang Y; Hou MX; Xie MJ; Zheng ZD Sci Rep; 2017 Feb; 7():42876. PubMed ID: 28216662 [TBL] [Abstract][Full Text] [Related]
31. WIF1 promoter hypermethylation induce endometrial carcinogenesis through the Wnt/β-catenin signaling pathway. Zhang B; Ji J; Hu M; Zhou X; Nie Q; Xu H; Jiang C; Fu Y; Li L Am J Reprod Immunol; 2023 Aug; 90(2):e13743. PubMed ID: 37491917 [TBL] [Abstract][Full Text] [Related]
32. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis. Huang Y; Xiang B; Liu Y; Wang Y; Kan H Cancer Lett; 2018 Nov; 437():56-66. PubMed ID: 30165194 [TBL] [Abstract][Full Text] [Related]
33. Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via miR-362-3p/DDX5 axis. Cui S; Zhang Y; Xing L; Li R; Piao Y; Liu H Environ Toxicol; 2022 Jun; 37(6):1483-1494. PubMed ID: 35343646 [TBL] [Abstract][Full Text] [Related]
34. AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer. Tian W; Tang Y; Luo Y; Xie J; Zheng S; Zou Y; Huang X; Wu L; Zhang J; Sun Y; Tang H; Du W; Li X; Xie X Cell Death Dis; 2023 Dec; 14(12):790. PubMed ID: 38040691 [TBL] [Abstract][Full Text] [Related]
35. MiR-431 suppresses proliferation and metastasis of lung cancer via down-regulating DDX5. Xu CM; Chen LX; Gao F; Zhu MF; Dai Y; Xu Y; Qian WX Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):699-707. PubMed ID: 30720177 [TBL] [Abstract][Full Text] [Related]
36. H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer. Guo M; Wang R; Nie M; Zhang H; Wang C; Song C; Niu S Cell Signal; 2024 Aug; 120():111196. PubMed ID: 38697448 [TBL] [Abstract][Full Text] [Related]
37. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts. Zhang Y; Liu Z; Yang X; Lu W; Chen Y; Lin Y; Wang J; Lin S; Yun JP Theranostics; 2021; 11(3):1473-1492. PubMed ID: 33391546 [No Abstract] [Full Text] [Related]
38. Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac Jin C; Wang T; Zhang D; Yang P; Zhang C; Peng W; Jin K; Wang L; Zhou J; Peng C; Tan Y; Ji J; Chen Z; Sun Q; Yang S; Tang J; Feng Y; Sun Y J Exp Clin Cancer Res; 2022 Dec; 41(1):345. PubMed ID: 36522719 [TBL] [Abstract][Full Text] [Related]
39. MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis. Zhai W; Ma J; Zhu R; Xu C; Zhang J; Chen Y; Chen Z; Gong D; Zheng J; Chen C; Li S; Li B; Huang Y; Xue W; Zheng J Br J Cancer; 2018 Aug; 119(5):591-604. PubMed ID: 30082686 [TBL] [Abstract][Full Text] [Related]
40. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma. Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R Int J Oncol; 2019 Apr; 54(4):1183-1194. PubMed ID: 30720068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]